120 related articles for article (PubMed ID: 9328577)
1. CTL responses induced by a single immunization with peptide encapsulated in biodegradable microparticles.
Partidos CD; Vohra P; Jones D; Farrar G; Steward MW
J Immunol Methods; 1997 Aug; 206(1-2):143-51. PubMed ID: 9328577
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable microparticles as a delivery system for measles virus cytotoxic T cell epitopes.
Partidos CD; Vohra P; Anagnostopoulou C; Jones DH; Farrar GH; Steward MW
Mol Immunol; 1996 Apr; 33(6):485-91. PubMed ID: 8700164
[TBL] [Abstract][Full Text] [Related]
3. Mucosal immunization with a measles virus CTL epitope encapsulated in biodegradable PLG microparticles.
Partidos CD; Vohra P; Jones DH; Farrar GH; Steward MW
J Immunol Methods; 1996 Sep; 195(1-2):135-8. PubMed ID: 8814328
[TBL] [Abstract][Full Text] [Related]
4. Priming of measles virus-specific CTL responses after immunization with a CTL epitope linked to a fusogenic peptide.
Partidos CD; Vohra P; Steward MW
Virology; 1996 Jan; 215(1):107-10. PubMed ID: 8553582
[TBL] [Abstract][Full Text] [Related]
5. Induction of cytotoxic T-cell responses following oral immunization with synthetic peptides encapsulated in PLG microparticles.
Partidos CD; Vohra P; Jones DH; Farrar G; Steward MW
J Control Release; 1999 Dec; 62(3):325-32. PubMed ID: 10528070
[TBL] [Abstract][Full Text] [Related]
6. Characterization of humoral and cellular immune responses in mice induced by immunization with HIV-1 Nef regulatory protein encapsulated in poly(DL-lactide-co-glycolide) microparticles.
Moureau C; Vidal PL; Bennasser Y; Moynier M; Nicaise Y; Aussillous M; Barthelemy S; Montagnier L; Bahraoui E
Mol Immunol; 2002 Jan; 38(8):607-18. PubMed ID: 11792429
[TBL] [Abstract][Full Text] [Related]
7. Microencapsulation of a synthetic peptide epitope for HTLV-1 in biodegradable poly(D,L-lactide-co-glycolide) microspheres using a novel encapsulation technique.
Frangione-Beebe M; Rose RT; Kaumaya PT; Schwendeman SP
J Microencapsul; 2001; 18(5):663-77. PubMed ID: 11508771
[TBL] [Abstract][Full Text] [Related]
8. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles.
Maloy KJ; Donachie AM; O'Hagan DT; Mowat AM
Immunology; 1994 Apr; 81(4):661-7. PubMed ID: 7518802
[TBL] [Abstract][Full Text] [Related]
9. CTL epitopes identified with a defective recombinant adenovirus expressing measles virus nucleoprotein and evaluation of their protective capacity in mice.
Schadeck EB; Partidos CD; Fooks AR; Obeid OE; Wilkinson GW; Stephenson JR; Steward MW
Virus Res; 1999 Dec; 65(1):75-86. PubMed ID: 10564754
[TBL] [Abstract][Full Text] [Related]
10. Induction of measles virus-specific cytotoxic T-cell responses after intranasal immunization with synthetic peptides.
Partidos CD; Vohra P; Steward MW
Immunology; 1996 Feb; 87(2):179-85. PubMed ID: 8698377
[TBL] [Abstract][Full Text] [Related]
11. Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles.
Vordermeier HM; Coombes AG; Jenkins P; McGee JP; O'Hagan DT; Davis SS; Singh M
Vaccine; 1995 Nov; 13(16):1576-82. PubMed ID: 8578845
[TBL] [Abstract][Full Text] [Related]
12. The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.
Lavelle EC; Yeh MK; Coombes AG; Davis SS
Vaccine; 1999 Feb; 17(6):512-29. PubMed ID: 10075157
[TBL] [Abstract][Full Text] [Related]
13. Poly(D,L-lactic-co-glycolic acid) microsphere delivery of adenovirus for vaccination.
Wang D; Molavi O; Lutsiak ME; Elamanchili P; Kwon GS; Samuel J
J Pharm Pharm Sci; 2007; 10(2):217-30. PubMed ID: 17706180
[TBL] [Abstract][Full Text] [Related]
14. Intranasal vaccination with poly(lactide-co-glycolide) microparticles containing a peptide T of Ole e 1 prevents mice against sensitization.
Marazuela EG; Prado N; Moro E; Fernández-García H; Villalba M; Rodríguez R; Batanero E
Clin Exp Allergy; 2008 Mar; 38(3):520-8. PubMed ID: 18205856
[TBL] [Abstract][Full Text] [Related]
15. Development of hepatitis B oral vaccine using B-cell epitope loaded PLG microparticles.
Rajkannan R; Dhanaraju MD; Gopinath D; Selvaraj D; Jayakumar R
Vaccine; 2006 Jun; 24(24):5149-57. PubMed ID: 16713035
[TBL] [Abstract][Full Text] [Related]
16. Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro.
Audran R; Peter K; Dannull J; Men Y; Scandella E; Groettrup M; Gander B; Corradin G
Vaccine; 2003 Mar; 21(11-12):1250-5. PubMed ID: 12559806
[TBL] [Abstract][Full Text] [Related]
17. Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres.
Men Y; Gander B; Merkle HP; Corradin G
Vaccine; 1996 Oct; 14(15):1442-50. PubMed ID: 8994320
[TBL] [Abstract][Full Text] [Related]
18. Structural requirements for synthetic immunogens to induce measles virus specific CTL responses.
Partidos CD; Delmas A; Steward MW
Mol Immunol; 1996 Nov; 33(16):1223-9. PubMed ID: 9129158
[TBL] [Abstract][Full Text] [Related]
19. Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity.
Nixon DF; Hioe C; Chen PD; Bian Z; Kuebler P; Li ML; Qiu H; Li XM; Singh M; Richardson J; McGee P; Zamb T; Koff W; Wang CY; O'Hagan D
Vaccine; 1996 Nov; 14(16):1523-30. PubMed ID: 9014294
[TBL] [Abstract][Full Text] [Related]
20. Linkage of a fusion peptide to a CTL epitope from the nucleoprotein of measles virus enables incorporation into ISCOMs and induction of CTL responses following intranasal immunization.
Hsu SC; Schadeck EB; Delmas A; Shaw M; Steward MW
Vaccine; 1996 Aug; 14(12):1159-66. PubMed ID: 8911014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
